2012 Q1 Activity. Paris, April 25, l Jean-Pierre Duprieu l Executive Vice-President l Fabienne Lecorvaisier l Chief Financial Officer

Transcription

1 2012 Q1 Activity Paris, April 25, 2012 l Jean-Pierre Duprieu l Executive Vice-President l Fabienne Lecorvaisier l Chief Financial Officer

2 2012 Q1 activity Paris, April 25, 2012 Sequential activity improvement Maintained investment cycle Operational indicators in line Creation of new segment in Healthcare 2 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

3 Group sales growing + 6.7% Sales in m Q Q1 12/11 Q1 12/11 Q as published comparable (1) pro forma Gas & Services 3,313 3, % +4.0% (2) Engineering & Construction % +31.9% 258 Other Activities % -7.4% 174 (2) Group Total 3,745 3, % +4.5% (1) excluding forex, natural gas and significant perimeter impacts (2) 2011 figures are restated for the transfer of Seppic from Other activities to the Healthcare segment within Gas and Services. 3 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

4 YoY growth improving despite high comparison basis G&S comparable growth (1) 12% 10% 8% % 11.4% 10.7% 11.0% 9.7% 8.3% 7.7% % 4% 2% 0% -2% 1.9% 4.0% -4% -6% -4.2% -5.1% -5.2% -4.6% Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 (1) excluding forex, natural gas and significant perimeter impacts 4 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

5 Activity level remaining strong Quarterly G&S activity indicator (1) base 100, average Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 (1) comparable revenue (excluding forex, natural gas and significant perimeter impacts), adjusted for the number of days per month 5 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

6 driven by developing economies excluding Electronics Comparable G&S sales growth (1) (Q1 2012/Q1 2011) G&S sales share in developing economies + 9% +0% + 36% + 5% * + 0% 15% 16% 19% 21% 22% + 21% + 15% Advanced economies Developing economies + 2% + 11% Q * Developing Asia at +10% excluding Electronics (1) Comparable growth: excluding forex, natural gas and significant perimeter impacts. 6 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

7 Sequential improvement in all zones Q G&S Sales: 3,443m 24% 2% 51% Q Q Comparable growth (1) 22% Highlights Europe 1,747m +1.4% +0.0% Contrasted situations Better IM pricing Strong growth in Central and Oriental Europe Americas 772m +5.3% +10.1% Better US Large Industries and Electronics Double digit IM in Canada and Latin America Solid Home healthcare in Argentina and Brazil Asia Pacific 840m +2.7% +1.3% Continuous growth in China Strong IM growth in Developing Asia Electronics stabilizing (Japan, Taiwan, Singapore) ME & Africa 84m +21.3% +16.5% Rebound after Arab Spring (1) excluding forex, natural gas and significant perimeter impacts 7 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

8 and in Industrial Merchant and Large Industries Industrial Merchant Large Industries 10% 20% +17% +17% 8% 5% 3% +4% +2% +3% +2% +4% 15% 10% 5% +11% +2% +7% 0% Q1 11 Q2 11 Q3 11 Q4 11 Q1 12 0% Q1 11 Q2 11 Q3 11 Q4 11 Q1 12 Electronics 37% Q1 37% 2012 Healthcare 17% 9% +28% 30% 10% 20% +19% +13% = excl. E&I 8% +8% +8% +7% +7% 10% 6% +6% 0% 4% -10% -20% -8% -11% 2% Q1 11 Q2 11 Q3 11 Q4 11 Q1 12 0% Q1 11 Q2 11 Q3 11 Q4 11 Q1 12 Comparable growth: excluding forex, natural gas and significant perimeter impacts, relative to the same period in preceding year 8 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

9 Solid activity in Engineering and Construction Third party E&C sales E&C order intake In m In m Q1 11 Q2 11 Q3 11 Q4 11 Q Q1 Q1 Q1 Q Good progress on projects in Q1 Third party air gas projects in China and HyCO in Canada 9 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

10 Current positive trends EOR Chemicals Healthcare Steel IM LI IM Electronics IM IM E&C Healthcare IM: Industrial Merchant LI: Large Industries - EOR: Enhanced Oil Recovery 10 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

11 Maintained investment momentum 12-month portfolio Investment of opportunities decisions Net capex (1) Start-ups (2) In bn 3.9 In bn In bn Q1 Q1 Q1 Q1 Q1 Q1 Q1 Q1 6 Dec-10 Dec-11 Mar e Developing Economies Advanced Economies (1) Industrial and financial investments, including transaction with minority shareholders, net of divestitures (2) Industrial projects > 10m 11 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

12 Operational indicators in line In bn 4 3 G&S sales % (1) 3.4 In bn 300 Group Efficiencies Annual objective 2012 > 200 M Q1 09 Q1 10 Q1 11 Q1 12 In bn 2 1,5 Net Capex (2) In bn Net debt ,5 0.5 Q1 Q1 Q1 Q end 2009 end 2010 end 2011 end Q1 12 (1) Comparable growth. (2) Industrial and financial investments, including transactions with minorities, net of divestitures 12 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment 4

13 2012 Q1 activity Creation of new segment in Healthcare Paris, April 25, 2012 l Jean-Pierre Duprieu l Executive Vice-President 13 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

14 Seppic, a growing business in Specialty Chemicals Seppic published revenues M 300 International expansion Major initiatives 2011: Divestitures to focus on healthcare specialties Ingredients for Health and Personal care USA, UK, China, Italy New vaccines adjuvants Production in China New countries April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

15 recognized for its leadership in Specialty Ingredients for Health and Personal Care Excipients and actives Adjuvants for vaccines Functional coating products with strong Innovation 136 patent families 100 researchers generating revenues (1) of 225M in 2011 Asia MEA France Americas Europe excl. France (1) Pro forma, following Commodities divestitures 600 employees in 15 countries 15 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

16 Specialty Ingredients joining Healthcare Health and Personal care products and services Common growth drivers and development strategy Medical expertise and Regulatory framework Before After With Specialty Ingredients Healthcare share in G&S 2011 revenues 16% 18% Gas & Services share in Group 2011 revenues 89% 90% 16 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

17 Healthcare 4 business segments Home Healthcare Medical gases Hygiene Specialty Ingredients + other local brands Respiratory Infusion and nutrition Medical gases and services Disinfectants and antiseptics for: Personal care Vaccines Pharmaceuticals Direct patient relationship Hospital oriented Health and personal care markets 17 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

18 Extended scope in Healthcare 2.3 bn 2011 pro forma revenue 30 countries > 700,000 patients 9,900 employees Specialty ingredients 10% Hygiene 15% 34% Medical Gases Home Healthcare 41% 18 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

19 Complementary growth initiatives 2010 / 2011 growth initiatives Healthcare revenue growth including Specialty Ingredients in m Home Healthcare, Medical gases and Hygiene Specialty Ingredients April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

20 Healthcare common growth drivers Home Healthcare Medical Gases Hygiene Specialty ingredients Ageing population Rising chronic diseases Growing Middle-class in developing economies Higher pandemic risk 20 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

21 2012 Q1 activity 2012 outlook Paris, April 25, 2012 l Jean-Pierre Duprieu l Executive Vice-President 21 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

22 2012 Outlook Q Sequential activity improvement Investment momentum and project activity maintained 2012 objective Barring a major economic downturn, Air Liquide continues to aim for growth in net profit in April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

23 Q Appendix 23 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

24 Impact of currency and natural gas on G&S revenue Currency In m Q1 11 Q2 11 Q3 11 Q4 11 Q1 12 /USD /CAD (59) (10) (43) (4) +5 (0) /JP Others (3) (22) +3 (13) Total currency impact +96 (94) (57) Average currency rate Q1 11 Q2 11 Q3 11 Q4 11 Q1 12 /USD /CAD /JP In m Natural Gas Natural Gas Impact April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

25 Revenue analysis by quarter (1) Sales in m (1) Q1 11 pro forma Q2 11 pro forma Q3 11 pro forma Q4 11 pro forma Q1 12 Q1 12/11 as published Q1 12/11 comparable (2) Europe 1,702 1,715 1,674 1,720 1, % +1.4% Americas % +10.1% Asia-Pacific % +2.7% Middle-East & Africa % +21.3% Gas & Services 3,240 3,235 3,276 3,313 3, % +4.0% Engineering & Construction % +31.9% Other Activities % -7.4% Group Total 3,543 3,573 3,597 3,745 3, % +4.5% (1) 2011 figures are restated for the transfer of Seppic from Other activities to the Healthcare segment within Gas and Services. (2) Excluding forex, natural gas and significant perimeter impacts 25 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

26 Revenue analysis by quarter (2) Sales in m Q1 11 Q2 11 Q3 11 Q4 11 (1) Q1 12 pro forma pro forma pro forma pro forma Q1 12/11 as published Q1 12/11 comparable (2) Industrial Merchant 1,200 1,199 1,238 1,256 1, % +4.4% Large Industries 1,133 1,121 1,157 1,174 1, % +7.3% Electronics % -10.8% Healthcare % +5.5% Gas & Services 3,240 3,235 3,276 3,313 3, % +4.0% Engineering & Construction % +31.9% Other Activities % -7.4% Group Total 3,543 3,573 3,597 3,745 3, % +4.5% (1) 2011 figures are restated for the transfer of Seppic from Other activities to the Healthcare segment within Gas and Services. (2) Excluding forex, natural gas and significant perimeter impacts 26 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

27 G&S Revenue growth by quarter (3) Growth as published Natural Gas Change Significant perimeter Comparable growth (1) Q % +0.8% +6.4% % Q % +0.5% +3.5% % Q % +1.6% -3.2% % Q % +1.0% -1.9% -0.9% +7.7% Q % +1.5% +0.8% -0.7% +1.9% Q % +0.7% +2.2% -0.6% +4.0% (1) excluding forex, natural gas and significant perimeter impacts 27 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

28 Europe in Q1 Industrial Merchant Better pricing in Western Europe Iberia still difficult Double digit growth in Developing Europe Large Industries Steel demand stabilizing Strong growth in Eastern Europe Site takeover in Turkey Healthcare Home healthcare solid growth despite tariff reductions High hygiene sales Q1 Gas & Services sales: 1,747m Electronics 3% Healthcare 27% 31% Industrial Merchant 39% Large Industries Q1 12/11 Comparable change (1) : % +0.5% Industrial Merchant +1.6% Large Industries Healthcare +4.6% 0% 3% 5% (1) excluding impact of change, natural gas and significant perimeter 28 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

29 Americas in Q1 Industrial Merchant New capacities for EOR (2) in Canada Dynamic Latin America Large Industries Strong chemical demand Site takeover in Louisiana Q1 Gas & Services sales: 772m Healthcare 8% 10% 34% Large Industries Electronics 48% Industrial Merchant Healthcare Strong growth in Latin America Electronics Activity pickup in the US (ESG and E&I) Q1 12/11 Comparable change (1) : +10.1% +8.6% Industrial Merchant +12.4% Large Industries +7.2% Healthcare +12.5% Electronics 0% 5% 10% 15% 20% (1) excluding impact of change, natural gas and significant perimeter (2) Oil Enhanced Recovery 29 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

30 Asia in Q1 Industrial Merchant Japan still difficult Back to solid growth outside Japan Q1 Gas & Services sales: 840m Electronics 23% 37% Healthcare Industrial Merchant 5% Large Industries 3 start-ups in China Solid demand across the zone Large Industries 35% Q1 12/11 Comparable change (1) : +2.7% Electronics Sharp E&I sales decrease compared to very high Q ESG stabilizing in Japan, Taiwan and Singapore Stable carrier gas sales -15.6% Industrial Merchant Large Industries +4.1% Electronics +16.6% -5% excl. E&I -18% -14% -10% -6% -2% 2% 6% 10% 14% 18% (1) excluding impact of change, natural gas and significant perimeter 30 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

31 Growth in Q G&S revenue in m +4.0% comparable (1) , <19> 3, % published growth Q Comparable growth (1) (1) excluding forex, natural gas and significant perimeter impacts Natural gas Change Scope Q April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

32 Industrial Merchant pricing Q Europe + 1.0% Americas + 4.3% Asia-Pacific + 0.4% Middle-East and Africa + 8.6% Total Industrial Merchant + 2.1% 32 April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment

33 For further information, please contact: Investor Relations Virginia Jeanson + 33 (0) Annie Fournier + 33 (0) Bastien Maurice + 33 (0) Communications Anne Lechevranton + 33 (0) Corinne Estrade-Bordry + 33 (0) Follow us on L Air Liquide S.A. Corporation for the study and application of processes developed by Georges Claude with registered capital of ,00 euros Corporate headquarters: 75, Quai d Orsay Paris Cedex 07 Tel : +33 (0) RCS Paris April 25, Q1 Revenue Air Liquide, world leader in gases for industry, health and the environment